Compound ID | 555
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against a number of species of Mycobacteria including M. tuberculosis, M. fortuitum and M. smegmatis |
| Description: | Renau TE, Gage JW, Dever JA, et al. Antituberculosis activity and side effect profiles of 8 new quinolones optimised for antimycobacterial effects. 36th-Intersci-Conf-Antimicrobial-Agents-Chemother 1996; 136. |
| Institute where first reported: | Parke Davis Pharmaceutical Research (Pfizer, USA) |
| Year first mentioned: | 1996 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6450951 |
| Citation: | https://journals.asm.org/doi/10.1128/aac.40.10.2363 |